According to Collegium Pharmaceutical 's latest financial reports and stock price the company's current Operating Margin is 9.19%. At the end of 2021 the company had an Operating Margin of -1.22%.
Year | Operating Margin | Change |
---|---|---|
2021 | -1.22% | -113.7% |
2020 | 8.90% | -216.18% |
2019 | -7.66% | -45.12% |
2018 | -13.95% | -94.69% |
2017 | -262.91% | -95.22% |
2016 | -5,504.15% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
United Therapeutics UTHR | 49.09% | 434.17% | ๐บ๐ธ USA |
Agile Therapeutics
AGRX | -451.32% | -5,010.99% | ๐บ๐ธ USA |
Horizon Therapeutics
HZNP | 14.06% | 52.99% | ๐ฎ๐ช Ireland |
KemPharm KMPH | -400.65% | -4,459.63% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.